Global Oral Proteins and Peptides Market Research Report 2024(Status and Outlook)

Global Oral Proteins and Peptides Market Research Report 2024(Status and Outlook)



Report Overview: Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc. The Global Oral Proteins and Peptides Market Size was estimated at USD 2969.16 million in 2023 and is projected to reach USD 6903.77 million by 2029, exhibiting a CAGR of 15.10% during the forecast period. This report provides a deep insight into the global Oral Proteins and Peptides market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oral Proteins and Peptides Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market. In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oral Proteins and Peptides market in any manner. Global Oral Proteins and Peptides Market: Market Segmentation Analysis The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments. Key Company Ironwood & Allergan Novo Nordisk Synergy Pharmaceuticals (Salix) Novartis Chiasma (Amryt Pharma) Market Segmentation (by Type) Linaclotide Insulin Plecanatide Cyclosporine Octreotide Market Segmentation (by Application) Gastric & Digestive Disorders Bone Diseases Diabetes Hormonal Disorders Geographic Segmentation • North America (USA, Canada, Mexico) • Europe (Germany, UK, France, Russia, Italy, Rest of Europe) • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) • South America (Brazil, Argentina, Columbia, Rest of South America) • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA) Key Benefits of This Market Research: • Industry drivers, restraints, and opportunities covered in the study • Neutral perspective on the market performance • Recent industry trends and developments • Competitive landscape & strategies of key players • Potential & niche segments and regions exhibiting promising growth covered • Historical, current, and projected market size, in terms of value • In-depth analysis of the Oral Proteins and Peptides Market • Overview of the regional outlook of the Oral Proteins and Peptides Market: Key Reasons to Buy this Report: • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change • This enables you to anticipate market changes to remain ahead of your competitors • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly • Provision of market value (USD Billion) data for each segment and sub-segment • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis • Provides insight into the market through Value Chain • Market dynamics scenario, along with growth opportunities of the market in the years to come • 6-month post-sales analyst support Customization of the Report In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met. Note: this report may need to undergo a final check or review and this could take about 48 hours. Chapter Outline Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods. Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oral Proteins and Peptides Market and its likely evolution in the short to mid-term, and long term. Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market. Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis. Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc. Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years. Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years. Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oral Proteins and Peptides
1.2 Key Market Segments
1.2.1 Oral Proteins and Peptides Segment by Type
1.2.2 Oral Proteins and Peptides Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oral Proteins and Peptides Market Overview
2.1 Global Market Overview
2.1.1 Global Oral Proteins and Peptides Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oral Proteins and Peptides Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oral Proteins and Peptides Market Competitive Landscape
3.1 Global Oral Proteins and Peptides Sales by Manufacturers (2019-2024)
3.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2019-2024)
3.3 Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oral Proteins and Peptides Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oral Proteins and Peptides Sales Sites, Area Served, Product Type
3.6 Oral Proteins and Peptides Market Competitive Situation and Trends
3.6.1 Oral Proteins and Peptides Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oral Proteins and Peptides Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oral Proteins and Peptides Industry Chain Analysis
4.1 Oral Proteins and Peptides Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oral Proteins and Peptides Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oral Proteins and Peptides Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oral Proteins and Peptides Sales Market Share by Type (2019-2024)
6.3 Global Oral Proteins and Peptides Market Size Market Share by Type (2019-2024)
6.4 Global Oral Proteins and Peptides Price by Type (2019-2024)
7 Oral Proteins and Peptides Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oral Proteins and Peptides Market Sales by Application (2019-2024)
7.3 Global Oral Proteins and Peptides Market Size (M USD) by Application (2019-2024)
7.4 Global Oral Proteins and Peptides Sales Growth Rate by Application (2019-2024)
8 Oral Proteins and Peptides Market Segmentation by Region
8.1 Global Oral Proteins and Peptides Sales by Region
8.1.1 Global Oral Proteins and Peptides Sales by Region
8.1.2 Global Oral Proteins and Peptides Sales Market Share by Region
8.2 North America
8.2.1 North America Oral Proteins and Peptides Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oral Proteins and Peptides Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oral Proteins and Peptides Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oral Proteins and Peptides Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oral Proteins and Peptides Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ironwood and Allergan
9.1.1 Ironwood and Allergan Oral Proteins and Peptides Basic Information
9.1.2 Ironwood and Allergan Oral Proteins and Peptides Product Overview
9.1.3 Ironwood and Allergan Oral Proteins and Peptides Product Market Performance
9.1.4 Ironwood and Allergan Business Overview
9.1.5 Ironwood and Allergan Oral Proteins and Peptides SWOT Analysis
9.1.6 Ironwood and Allergan Recent Developments
9.2 Novo Nordisk
9.2.1 Novo Nordisk Oral Proteins and Peptides Basic Information
9.2.2 Novo Nordisk Oral Proteins and Peptides Product Overview
9.2.3 Novo Nordisk Oral Proteins and Peptides Product Market Performance
9.2.4 Novo Nordisk Business Overview
9.2.5 Novo Nordisk Oral Proteins and Peptides SWOT Analysis
9.2.6 Novo Nordisk Recent Developments
9.3 Synergy Pharmaceuticals (Salix)
9.3.1 Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides Basic Information
9.3.2 Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides Product Overview
9.3.3 Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides Product Market Performance
9.3.4 Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides SWOT Analysis
9.3.5 Synergy Pharmaceuticals (Salix) Business Overview
9.3.6 Synergy Pharmaceuticals (Salix) Recent Developments
9.4 Novartis
9.4.1 Novartis Oral Proteins and Peptides Basic Information
9.4.2 Novartis Oral Proteins and Peptides Product Overview
9.4.3 Novartis Oral Proteins and Peptides Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Recent Developments
9.5 Chiasma (Amryt Pharma)
9.5.1 Chiasma (Amryt Pharma) Oral Proteins and Peptides Basic Information
9.5.2 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Overview
9.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Market Performance
9.5.4 Chiasma (Amryt Pharma) Business Overview
9.5.5 Chiasma (Amryt Pharma) Recent Developments
10 Oral Proteins and Peptides Market Forecast by Region
10.1 Global Oral Proteins and Peptides Market Size Forecast
10.2 Global Oral Proteins and Peptides Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oral Proteins and Peptides Market Size Forecast by Country
10.2.3 Asia Pacific Oral Proteins and Peptides Market Size Forecast by Region
10.2.4 South America Oral Proteins and Peptides Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oral Proteins and Peptides by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oral Proteins and Peptides Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oral Proteins and Peptides by Type (2025-2030)
11.1.2 Global Oral Proteins and Peptides Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oral Proteins and Peptides by Type (2025-2030)
11.2 Global Oral Proteins and Peptides Market Forecast by Application (2025-2030)
11.2.1 Global Oral Proteins and Peptides Sales (Kilotons) Forecast by Application
11.2.2 Global Oral Proteins and Peptides Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings